The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...

The team is exploring whether biomarker testing could also identify patients who benefit more from immune checkpoint inhibitors after radiation.

Nine months cancer-free, Tiffiney Beard never missed a day of work during her three-month treatment with the new proton ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

After establishing dosing and safety in Phase I, researchers will evaluate the drug's anti-tumor activity in patients with PSMA-expressing cancers.

An international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of ...

An international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as the researchers show, the protein PPARγ, which is ...

Mohammad Mahmoud, MD, MS, reviews important updates in metastatic prostate cancer presented at AUA 2025, including promising ...

An investigational viral immunotherapy extended survival compared with standard care for patients with advanced non-small cell lung cancer who had inadequate response to immune checkpoint inhibitor ...

Glioblastoma may be driven by 3D DNA folding patterns, not just mutations, offering new paths for treatment. A new ...

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...